Flexion Therapeutics, Inc. announced that Christina Willwerth has been named Chief Strategy Officer. Ms. Willwerth joined Flexion in June 2009, and she most recently served as the company's Senior Vice President of Program Management and Strategy. In her expanded role, Ms. Willwerth will continue to lead the planning and execution of the company's strategic vision and priorities, and she has accountability for Flexion's portfolio development efforts and Human Resources activities. Ms. Willwerth has 25 years of experience in pharmaceutical development. Prior to joining Flexion, she served as Vice President, Product Development at Viacell and was a member of the company's executive management team. Previously she served as Senior Director, Product Development at The Medicines Company, where she focused on clinical and product development for cardiovascular therapies.